Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset
First Prev 1 2 3 4 Next Last

  • Alshammari, F. S., Petrofsky, J. S., Daher, N., Alzoghbieh, E. S., Dehom, S. O., & Laymon, M. S. (2014). Tactile intervention as a novel technique in improving body stability in healthy elderly and elderly with diabetes. Diabetes Technology & Therapeutics, 16(12), 822-827. doi:10.1089/dia.2014.0183

    		•

  • Alsubiheen, A., Petrofsky, J. S., Daher, N., Lohman, E., & Balbas, E. (2015). Effect of tai chi exercise combined with mental imagery theory in improving balance in a diabetic and elderly population. Medical Science Monitor, 21, 3054-3061. doi:10.12659/MSM.894243

    		•

  • Argo, T., Carnahan, R., Barnett, M. J., Holman, T., & Perry, P. J. (2011). Diabetes prevalence estimates in schizophrenia and risk factor assessment. Annals of Clinical Psychiatry, 23(2), 117-124.

  • Aruoma, O. I., Narrain, D., Indelicato, J., Bourdon, E., Murad, F. & Bahorun, T. (2014). Cognitive impairment in patients with type 2 diabetes mellitus: Perspectives and challenges. Archives of Medical and Biomedical Research, 1(2), 79-89. This material can be found here.

  • Askari, B., Wietecha, T., Hudkins, K. L., Fox, E. J., O'Brien, K. D., Kim, J., . . . Alpers, C. E. (2014). Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse. Laboratory Investigation, 94, 851–862. doi:10.1038/labinvest.2014.80

    		•

  • Baginsky, P. R., Jolicoeur, M., Hurlbert, L., & Revels, J. (2011). Skin autofluorescence: A tool for identification of prediabetes (preDM) and diabetes (DM). Diabetes, 60(Suppl. 1), A328-329. doi:10.2337/db11-868-1281

    		•

  • Banthia, S., Bergner, D. W., Chicos, A. B. , Ng, J., Pelchovitz, D. J., Subacius, H., . . . Kadish, A. H. (2013). Detection of cardiovascular autonomic neuropathy using exercise testing in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 27(1), 64–69. doi: 10.1016/j.jdiacomp.2012.09.002

    		•

  • Casapulla, S. L., Howe, C. A., Mora, G. R., Berryman, D., Frijalva, M. J., Rojas, E. W., . . . Shubrook, J. H. (2017). Cardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador. Diabetology & Metabolic Syndrome, 9 [Article 24]. This material can be found here.

  • Chamberlain, J. J., Herman, W. H., Leal, S., Rhinehart, A. S., Shubrook, J. H., Skolnik, N., & Kalyani, R. R. (2017). Pharmacologic therapy for type 2 diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine, 166(8), 572-578. This material can be found here.

  • Choy, M. (2008, August). New combination pill approved for Type 2 diabetes. Drug Topics. This material can be found here.

  • Choy, M., & Lam, S. (2007). Sitagliptin: A novel drug in the treatment of type 2 diabetes. Cardiology in Review, 15(5), 264-271. doi:10.1097/CRD.0b013e318123f771

    		•

  • Choy, M., & Richman, M. (2013). Standards of medical care in diabetes: Focus on updated recommendations in hospitalized patients. Formulary, 48(6), 189-191.

  • Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Diabetes management within evolving health care delivery models: The osteopathic perspective [Supplemental material]. Journal of the American Osteopathic Association, 115, eS5-eS7. This material can be found here.

  • Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform [Supplemental material]. Journal of the American Osteopathic Association, 115, eS8-eS19. This material can be found here.

  • Clearfield, M. B. (2011). Combination lipid therapy in type 2 diabetes. Current Atherosclerosis Reports, 13(1), 1-3. doi:10.1007/s11883-010-0139-y

    		•

  • Cohen, K. R., Shinkazh, N., Frank, J., Israel, I., & Fellner, C. (2015). Pharmacological treatment of diabetic peripheral neuropathy. P & T, 40(6), 372, 375-388. This material can be found here.

  • de Groot, M., Crick, K. A., Long, M., Saha, C., & Shubrook, J. H. (2016). Lifetime duration of depressive disorders in patients with type 2 diabetes. Diabetes Care, 39(12), 2174-2181. doi:10.2337/dc16-1145

    		•

  • de Groot, M. Shubrook, J. H., Schwartz, F., Hornsby Jr., W. G., Pillay, Y., & Saha, C. (2015). Program ACTIVE II: Design and methods for a multi-center community-based depression treatment for rural and urban adults with type 2 diabetes. Journal of Diabetes Research and Therapy, 1(2). This material can be found here.

  • Dugan, J. A. (2016). Exercise recommendations for patients with type 2 diabetes. Journal of the American Academy of Physician Assistants, 29(1), 13-18. doi:10.1097/01.JAA.0000475460.77476.f6

    		•

  • Dugan, J. A. (2017). Standards of care and treatment in diabetes. Physician Assistant Clinics, 2(1), 13-23. doi:10.1016/j.cpha.2016.08.004

    		•

  • Dugan, J. A. & Parthasarathy, A. (2016). Managing diabetes in women of childbearing age. Clinician Reviews, 26(2), 51-55. This material can be found here.

  • Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015). Hypoglycemia in type 2 diabetes - More common than you think: A continuous glucose monitoring study. Journal of Diabetes Science and Technology, 9(5), 999-1005. doi:10.1177/1932296815581052

    		•

  • Gerencser, A. A. (2015). Bioenergetic analysis of single pancreatic β-cells indicates an impaired metabolic signature in type 2 diabetic subjects. Endocrinology, 156(10), 3496-3503. doi:10.1210/en.2015-1552

    		•

  • Goswami, G., Shinkazh, N., & Davis, N. (2014). Optimal pharmacologic treatment strategies in obesity and type 2 diabetes. Journal of Clinical Medicine, 3(2), 595-613. doi:10.3390/jcm3020595

    		•

  • Grasso, Y. Z., Reddy, S. K., Rosenfeld, C. R., Hussein, W. I., Hoogwerf, B. J., Faiman, C., & Gupta, M. K. (2001). Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: Prevalence and correlation with clinical features. Endocrine Practice, 7(5), 339-345. doi:10.4158/EP.7.5.339

    		•
First Prev 1 2 3 4 Next Last